{"id":1409,"date":"2025-06-03T16:46:21","date_gmt":"2025-06-03T14:46:21","guid":{"rendered":"https:\/\/www.sunrockbiopharma.com\/?p=1409"},"modified":"2025-06-03T16:46:52","modified_gmt":"2025-06-03T14:46:52","slug":"nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas","status":"publish","type":"post","link":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/","title":{"rendered":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas"},"content":{"rendered":"<p><span class=\"break-words tvm-parent-container\"><span dir=\"ltr\">SRB2 es un <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23anticuerpo&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>anticuerpo<\/a> monoclonal humanizado desarrollado por <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/sunrock-biopharma\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">SunRock Biopharma, S.L<\/a> cuya diana es <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23ccr9&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>CCR9<\/a>.<\/span><\/span><\/p>\n<p>\ud83c\udfaf Este estudio demuestra la eficacia de SRB2 mediante citotoxicidad celular dependiente de anticuerpos (<a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23adcc&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>ADCC<\/a>) en c\u00e9lulas de c\u00e1ncer de p\u00e1ncreas, as\u00ed como su actividad en <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23organoides&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>organoides<\/a> derivados de pacientes y en modelos de <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23xenoinjerto&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>xenoinjerto<\/a>, en los que se logra incluso <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23regresi%C3%B3n&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>regresi\u00f3n<\/a> <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23tumoral&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>tumoral<\/a> completa en un n\u00famero significativo de animales. Estos resultados respaldan el desarrollo de SRB2 como un candidato <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23terap%C3%A9utico&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>terap\u00e9utico<\/a> prometedor para el <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23c%C3%A1ncer&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>c\u00e1ncer<\/a> de <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23p%C3%A1ncreas&amp;origin=HASH_TAG_FROM_FEED\" data-test-app-aware-link=\"\"><span aria-hidden=\"true\">#<\/span>p\u00e1ncreas<\/a>.<\/p>\n<p>Este trabajo es fruto de una excelente colaboraci\u00f3n entre la <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/universityofkentucky\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">University of Kentucky<\/a>, la <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/universidad-de-santiago-de-compostela\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">Universidade de Santiago de Compostela<\/a> (<a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/cimus\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">CiMUS (Center for Research in Molecular Medicine and Chronic Diseases)<\/a> y <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/sunrock-biopharma\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">SunRock Biopharma, S.L<\/a>. Estamos muy agradecidos a todos los autores por su contribuci\u00f3n cient\u00edfica. \ud83e\udd1d<\/p>\n<p>\ud83d\udd17 El art\u00edculo completo aqu\u00ed: <a class=\"FYFwKXYNhRNjjSvOyrNhgyvQhtApFmdaFNvUxIg \" tabindex=\"0\" href=\"https:\/\/lnkd.in\/dk3ZieTH\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">https:\/\/lnkd.in\/dk3ZieTH<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SRB2 es un #anticuerpo monoclonal humanizado desarrollado por SunRock Biopharma, S.L cuya diana es #CCR9. \ud83c\udfaf Este estudio demuestra la eficacia&#8230;<\/p>\n","protected":false},"author":1,"featured_media":1406,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[19],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v17.7.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma<\/title>\r\n<meta name=\"robots\" content=\"noindex, follow\" \/>\r\n<meta property=\"og:locale\" content=\"es_ES\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma\" \/>\r\n<meta property=\"og:description\" content=\"SRB2 es un #anticuerpo monoclonal humanizado desarrollado por SunRock Biopharma, S.L cuya diana es #CCR9. \ud83c\udfaf Este estudio demuestra la eficacia...\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/\" \/>\r\n<meta property=\"og:site_name\" content=\"SunRock Biopharma\" \/>\r\n<meta property=\"article:published_time\" content=\"2025-06-03T14:46:21+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2025-06-03T14:46:52+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1187\" \/>\r\n\t<meta property=\"og:image:height\" content=\"458\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"SunRock\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#organization\",\"name\":\"SunRock Biopharma\",\"url\":\"https:\/\/www.sunrockbiopharma.com\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#logo\",\"inLanguage\":\"es\",\"url\":\"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2020\/09\/sunrock-seo-fb.png\",\"contentUrl\":\"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2020\/09\/sunrock-seo-fb.png\",\"width\":1201,\"height\":631,\"caption\":\"SunRock Biopharma\"},\"image\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#website\",\"url\":\"https:\/\/www.sunrockbiopharma.com\/\",\"name\":\"SunRock Biopharma\",\"description\":\"Solutions for cancer therapy\",\"publisher\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sunrockbiopharma.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage\",\"inLanguage\":\"es\",\"url\":\"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg\",\"contentUrl\":\"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg\",\"width\":1187,\"height\":458},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#webpage\",\"url\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/\",\"name\":\"Nueva publicaci\\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\\u00e1ncreas | SunRock Biopharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage\"},\"datePublished\":\"2025-06-03T14:46:21+00:00\",\"dateModified\":\"2025-06-03T14:46:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sunrockbiopharma.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nueva publicaci\\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\\u00e1ncreas\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#webpage\"},\"author\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#\/schema\/person\/4ea2f25ba0ae14f007cd36bc8c8550ea\"},\"headline\":\"Nueva publicaci\\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\\u00e1ncreas\",\"datePublished\":\"2025-06-03T14:46:21+00:00\",\"dateModified\":\"2025-06-03T14:46:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#webpage\"},\"wordCount\":171,\"publisher\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg\",\"articleSection\":[\"noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#\/schema\/person\/4ea2f25ba0ae14f007cd36bc8c8550ea\",\"name\":\"SunRock\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sunrockbiopharma.com\/#personlogo\",\"inLanguage\":\"es\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e49e14e1d27c5f474f91bf5035dbde13?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e49e14e1d27c5f474f91bf5035dbde13?s=96&d=mm&r=g\",\"caption\":\"SunRock\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma","robots":{"index":"noindex","follow":"follow"},"og_locale":"es_ES","og_type":"article","og_title":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma","og_description":"SRB2 es un #anticuerpo monoclonal humanizado desarrollado por SunRock Biopharma, S.L cuya diana es #CCR9. \ud83c\udfaf Este estudio demuestra la eficacia...","og_url":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/","og_site_name":"SunRock Biopharma","article_published_time":"2025-06-03T14:46:21+00:00","article_modified_time":"2025-06-03T14:46:52+00:00","og_image":[{"width":1187,"height":458,"url":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"SunRock","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/www.sunrockbiopharma.com\/#organization","name":"SunRock Biopharma","url":"https:\/\/www.sunrockbiopharma.com\/","sameAs":[],"logo":{"@type":"ImageObject","@id":"https:\/\/www.sunrockbiopharma.com\/#logo","inLanguage":"es","url":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2020\/09\/sunrock-seo-fb.png","contentUrl":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2020\/09\/sunrock-seo-fb.png","width":1201,"height":631,"caption":"SunRock Biopharma"},"image":{"@id":"https:\/\/www.sunrockbiopharma.com\/#logo"}},{"@type":"WebSite","@id":"https:\/\/www.sunrockbiopharma.com\/#website","url":"https:\/\/www.sunrockbiopharma.com\/","name":"SunRock Biopharma","description":"Solutions for cancer therapy","publisher":{"@id":"https:\/\/www.sunrockbiopharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sunrockbiopharma.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"ImageObject","@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage","inLanguage":"es","url":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","contentUrl":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","width":1187,"height":458},{"@type":"WebPage","@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#webpage","url":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/","name":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma","isPartOf":{"@id":"https:\/\/www.sunrockbiopharma.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage"},"datePublished":"2025-06-03T14:46:21+00:00","dateModified":"2025-06-03T14:46:52+00:00","breadcrumb":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sunrockbiopharma.com\/es\/"},{"@type":"ListItem","position":2,"name":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas"}]},{"@type":"Article","@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#article","isPartOf":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#webpage"},"author":{"@id":"https:\/\/www.sunrockbiopharma.com\/#\/schema\/person\/4ea2f25ba0ae14f007cd36bc8c8550ea"},"headline":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas","datePublished":"2025-06-03T14:46:21+00:00","dateModified":"2025-06-03T14:46:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#webpage"},"wordCount":171,"publisher":{"@id":"https:\/\/www.sunrockbiopharma.com\/#organization"},"image":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","articleSection":["noticias"],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.sunrockbiopharma.com\/#\/schema\/person\/4ea2f25ba0ae14f007cd36bc8c8550ea","name":"SunRock","image":{"@type":"ImageObject","@id":"https:\/\/www.sunrockbiopharma.com\/#personlogo","inLanguage":"es","url":"https:\/\/secure.gravatar.com\/avatar\/e49e14e1d27c5f474f91bf5035dbde13?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e49e14e1d27c5f474f91bf5035dbde13?s=96&d=mm&r=g","caption":"SunRock"}}]}},"_links":{"self":[{"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/posts\/1409"}],"collection":[{"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/comments?post=1409"}],"version-history":[{"count":2,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/posts\/1409\/revisions"}],"predecessor-version":[{"id":1411,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/posts\/1409\/revisions\/1411"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/media\/1406"}],"wp:attachment":[{"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/media?parent=1409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/categories?post=1409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/tags?post=1409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}